Deans' stroke musings: This Common Medication Could Save You From Deadly COVID Complications

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, October 23, 2020

This Common Medication Could Save You From Deadly COVID Complications

I'm not waiting for a clinical trial, anyway I'm already taking 325 daily and seem to have zero gastrointestinal bleeding. I would suggest the reason is the blood thinning capabilities of aspirin.
This Common Medication Could Save You From Deadly COVID Complications

Kali Coleman

Fri, October 23, 2020, 11:59 AM EDT

With the pandemic continuing to progress, many people are focused on how they can protect themselves from a serious case of coronavirus. After all, the more complications you experience during a COVID infection, the likelier you are to face a fatal outcome. Now, recent research may be providing people with a new way to guard themselves. According to new study, aspirin may be able to save you from deadly COVID complications. Read on to find out how this over-the-counter medication can help, and for more coronavirus news, discover How Bad the COVID Outbreak Is in Your State.

A study conducted by the University of Maryland School of Medicine (UMSOM) and published Oct. 22 in the Anesthesia and Analgesia journal looked at the medical records of more than 400 coronavirus patients who were hospitalized from March to July due to complications from their infection. A little more than 23 percent of these patients were taking a daily low dose of aspirin (usually 81 milligrams) either before being admitted or right after being admitted to the hospital to manage cardiovascular disease.

Researchers found that hospitalized COVID patients who took a daily low dose of aspirin had a significantly lower risk of complications and death from the virus. Aspirin users were 43 percent less likely to be put in the intensive care unit (ICU) and 44 percent less likely to be placed on a ventilator. They also had a 47 percent decrease in the risk of dying from their coronavirus infection compared to hospitalized patients who were not taking daily aspirin doses.

aspirin bottle on table possibly for covid complications

"This is a critical finding that needs to be confirmed through a randomized clinical trial," study leader Jonathan Chow, MD, an assistant professor of anesthesiology at UMSOM, said in a statement. "If our finding is confirmed, it would make aspirin the first widely available, over-the-counter medication to reduce mortality in COVID-19 patients."

The use of aspirin may be helpful in counteracting the risk of blood clots that can form in coronavirus patients. In May, an Atlanta doctor said that 20 to 40 percent of COVID patients in the city's hospitals were developing blood clots. Then a July study found that more than 31 percent of hospitalized COVID patients ended up having severe complications from blood clots. In general, blood clots can lead to dangerous and sometimes fatal health problems, including heart attacks, strokes, and multiple organ failure.

"We believe that the blood thinning effects of aspirin provides benefits for COVID-19 patients by preventing microclot formation," study co-author Michael A. Mazzeffi, MD, an associate professor of anesthesiology at UMSOM, said in a statement. "Patients diagnosed with COVID-19 may want to consider taking a daily aspirin, as long as they check with their doctor first."